NCT06591442

Brief Summary

To determine the high risk factors affecting accelerated recovery after spinal fusion surgery in advanced age patient.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
17mo left

Started Sep 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
Sep 2024Sep 2027

Study Start

First participant enrolled

September 3, 2024

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

September 7, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 3, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 3, 2027

Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3 years

First QC Date

September 7, 2024

Last Update Submit

September 7, 2024

Conditions

Keywords

Enhanced recovery after surgery (ERAS)Spinal fusion surgeryAdvanced age patientHigh risk factors

Outcome Measures

Primary Outcomes (1)

  • Safety Metrics for Enhanced Recovery After Spinal Fusion Surgery

    Blood routine examination, blood biochemistry, coagulation function, imaging examination (X-ray, CT 3D reconstruction). The number of participants for all adverse events, serious adverse events, implant-related adverse events and drug-related serious adverse events, and the adverse events were summarized accordingly. The severity of adverse events will be rated according to NCI-CTCAE version 4.0.

    Baseline. 7 days, 3 months, 6 months, 9 months and 12 months after surgery

Study Arms (2)

Elderly group patients (60-74 years).

Diagnostic Test: This is an observational study

Advanced age group patients (≥75 years)

Diagnostic Test: This is an observational study

Interventions

This study divides the elderly population into two groups: the Elderly group and the Advanced age group. By observing the enhanced recovery after spinal fusion surgery in these two distinct age groups of elderly patients, risk factors affecting postoperative enhanced recovery will be identified. Detection index: Blood routine examination, blood biochemistry, coagulation function, imaging examination (X-ray, CT 3D reconstruction), Japanese Orthopaedic Association (JOA) score, visual analogue scale (VAS) pain score. The number of participants for all adverse events, serious adverse events, implant-related adverse events and drug-related serious adverse events, and the adverse events were summarized accordingly. The severity of adverse events will be rated according to NCI-CTCAE version 4.0.

Advanced age group patients (≥75 years)Elderly group patients (60-74 years).

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Department of Orthopedics, Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology, China

You may qualify if:

  • Informed consent signed and dated by subject or guardian
  • Commit to follow the research procedures and cooperate with the whole process of the study
  • The subjects are 60 years old or older, regardless of gender
  • Patients with degenerative spinal diseases requiring spinal fusion surgery
  • Generally in good physical condition
  • Able to adhere to and cooperate with research interventions, such as oral medication
  • In fertile women, contraception should be used for at least one month prior to screening, and they should commit to use contraception throughout the study period and continue until the specified time after the study

You may not qualify if:

  • Acute infection
  • Congenital malformation
  • Abnormal anatomy or skeletal variation
  • Malignant tumor
  • The surgical area was locally infected with symptoms of local inflammation
  • Fever or leukocytosis
  • Morbid obesity
  • Pregnant and nursing women
  • Mental illness
  • Acute joint disease, bone resorption, osteopenia and/or osteoporosis. Osteoporosis is a relative contraindication, as this condition may limit the degree of correction that can be produced, the amount of mechanical fixation, and/or the quality of the bone graft
  • Patients who are unwilling to cooperate with post-operative treatment
  • Any time an implant is performed it interferes with the anatomy or intended physiological function of the patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedics, Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430023

Wuhan, Hubei, 430023, China

Location

MeSH Terms

Conditions

Intervertebral Disc DisplacementSpinal StenosisSpondylolisthesisRadiculopathy

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSpondylolysisSpondylosisPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of orthopedics; Professor

Study Record Dates

First Submitted

September 7, 2024

First Posted

September 19, 2024

Study Start

September 3, 2024

Primary Completion (Estimated)

September 3, 2027

Study Completion (Estimated)

September 3, 2027

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations